Medicine recalls, drug alerts and medical device warnings from the MHRA. 609 listed.
(Uab Norameda) distributor Peckforton Pharmaceuticals Limited has identified an error on the presentation of the 50ml carton - the coloured band on the package should be purple not pink although text is correct (EL(15)A/06).
(CooperSurgical under different brand names) Risk of serious burn if device is used past its expiry date (MDA/2015/025)
(Generics (UK) Limited, trading as Mylan UK) A small number of packs from a specific batch may have an over count or under count of one tablet (EL (15)A/05).
(RelonChem Ltd/ Kent Pharmaceuticals) All unexpired batches of 50mg Tramadol capsules are being recalled due to the risk of fungal contamination. Class 2 – action within 48 hours. (EL (15)A/04)
(Allergan UK Limited) Specific batch including a Danish language pack was shipped to the UK in error. Class 3 – action within 5 days. (EL (15)A/03)
Sanofi is recalling a specific batch of syringe barrels used in batch 4LL66 of this product, distributed from 12 January 2015.
(Aventis Pharma Limited and Winthrop Pharmaceuticals UK Limited) The smell associated with some batches is said to be a result of the foil packaging, but patients should continue taking their medicine. (EL (15)A/02)
Takeda UK Ltd is recalling a specific batch of Vitaros 3mg/g cream 4 x 100mg.
Takeda UK Ltd is recalling specific batches of Rienso 30mg/ml solution for infusion (Ferumoxytol).
(Novartis Consumer Health UK Limited and Actavis Group PTC EHF): Product reclassified from P to POM due to safety concerns – class 2 action within 48 hours (EL (15)A/01)
(Lundbeck Limited) May result in suboptimal dosage of the product - class 2 action within 48 hours. (EL (14)A/19)
(Medtronic) Risk due to incorrect selection and delivery of bolus amount. (MDA/2014/019)
(Roche Diagnostics Ltd) Increased risk that the vibration alarm will not work as a result of a changed component. (MDA/2014/008)
(Medtronic) May lead to severe hypoglycaemia (low blood glucose) or severe hyperglycaemia (high blood glucose). (MDA/2013/035)
(Covidien) reports of serious injuries after use of Stapler Duet TRS™ loading units in the thoracic cavity.(MDA/2012/005)
(Covidien) device may spontaneously energize when clamping during diathermy (electrosurgery) procedures without pushing the activation button, which could lead to unintended energy delivery to tissue. (MDA/2011/026)
(GlaxoSmithKline) Check each vial for cracks by turning upside down and looking for chips, cracks or damage where base meets side wall. (EL (14)A/15)
(McNeil Products Limited) Remaining stocks of the above products should be quarantined - class 2 action within 48 hours. (EL (14)A/14)
(Teva UK Limited) red precipitate found during stability testing under cold storage conditions - class 2 action within 48 hours. (EL (14)A/13)
(ViroPharma SPRL) Pharmacists should quarantine batches and return them to original wholesaler for credit - class 2 action within 48 hours. (EL (14)A/12)
(Wockhardt UK Ltd) Remaining stock from affected batches should be quarantined and returned to the original supplier for credit - class 2 action within 48 hours. (EL (14)A/11)
(Penn Pharma, distributed in Quantum Pharmaceutical livery) May result in evaporation of aqueous component of product and increase in concentration of Midazolam. (EL (14)/A10)
(Wockhardt UK Ltd) Should not be used in neonates and infants under 1 year old until further notice. (EL (14)A/09)
(Reckitt Benckiser Healthcare (UK) Limited) Remaining stock of batches should be quarantined and returned to original supplier for credit. - class 2 action within 48 hours. (EL (14)A/08)